CD8A and neoplasm: Enhanced myeloid cell content, skewing of Treg/Teff ratios, and loss of CD8+ cytotoxic T‐cells have all been associated with iCAF‐enriched tumour models, indicating potential immune suppressive roles [29, 49]; here, a combination with appropriate checkpoint blockade may be of value.